CHANGES AND CLINICAL INDICATIONS OF INTERLEUKIN -2 RECEPTOR, FERRITIN AND FIBRINECTIN IN THE CEREBROSPINAL FLUID OF CENTRAL NERVOUSE SYSTEM LEUKEMIA
10.3969/j.issn.1671-332X.2014.07.021
- VernacularTitle:中枢神经系统白血病脑脊液中白细胞介素2受体、铁蛋白和纤维结合蛋白的变化及其临床意义
- Author:
Qing LI
- Publication Type:Journal Article
- Keywords:
Central nervous system leukemia;
Soluble interleukin-2 receptor;
Ferritin;
Fibronectin
- From:
Modern Hospital
2014;(7):54-55
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the changes and clinical indications of interleukin-2 receptor, ferritin and fi-brinectin in the cerebrospinal fluid of central nervous system leukemia.Methods ELISA was used to detect the changes of-soluble interleukin-2 receptor, ferritin and fibrinectin in the cerebrospinal fluid of central nervous system leukemia group ( CNSL) and non-CNSL group.Results The concentrations of soluble interleukin-2 receptor, ferritin and fibronectin ince-rebrospinal fluid of the CNSL group were significantly higher than those in non -CNSL group and the control group ( p <0.05).Conclusion The soluble interleukin 2 receptor, ferritin and fibronectin in cerebrospinal fluid are indicative of cen-tral nervous system leukemia.The result suggests that combined detection is important in early diagnosis of central nervous system leukemia.
